SCHEMBL31322129

SCHEMBL31322129

Oc1ccc(Oc2cc(C=Cc3cc(O)c(O)c(O)c3)cc(Oc3ccc(O)cc3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
ALOX5 P09917 5/20 0.51
CYP1A1 P04798 4/20 0.51
CYP1B1 Q16678 4/20 0.51
KDM4E B2RXH2 4/20 0.51
MAPT P10636 4/20 0.51
TTR P02766 4/20 0.51
PTGS2 P35354 3/20 0.51
PTGS1 P23219 3/20 0.51
NQO2 P16083 3/20 0.51
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
GFER P55789 3/20 0.51
HDAC6 Q9UBN7 3/20 0.51
ABL1 P00519 2/20 0.51
ABCB1 P08183 2/20 0.51
GAA P10253 2/20 0.51
BCR P11274 2/20 0.51
MAPK1 P28482 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31322155 0.85 PTGS2 (0.61) MEN1KMT2AALOX5CYP1A1CYP1B1
SCHEMBL2521178 0.79 CYP1A1 (0.61) MEN1KMT2AALOX5CYP1A1CYP1B1
SCHEMBL2521181 0.79 CYP1A1 (0.61) MEN1KMT2AALOX5CYP1A1CYP1B1
SCHEMBL718526 0.78 PTGS1 (0.69) MEN1KMT2AALOX5CYP1A1CYP1B1
SCHEMBL718527 0.78 PTGS1 (0.69) MEN1KMT2AALOX5CYP1A1CYP1B1
SCHEMBL16551547 0.78 MEN1 (0.82) MEN1KMT2AKDM4EMAPTNPC1
SCHEMBL1393726 0.74 LCK (0.74) MEN1KMT2AALOX5CYP1A1CYP1B1
SCHEMBL1393728 0.74 LCK (0.74) MEN1KMT2AALOX5CYP1A1CYP1B1
SCHEMBL2513436 0.74 CYP1A1 (0.65) MEN1KMT2AALOX5CYP1A1CYP1B1
SCHEMBL2513437 0.74 CYP1A1 (0.65) MEN1KMT2AALOX5CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP claimed
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP disclosed